## Abstract The immunogenic effect of inactivated hepatitis B vaccine (Merck Heptavax B) was evaluated in 202 seronegative healthy medical personnel. Three inoculations of vaccine were given at 1‐month intervals. Of 116 vaccinees who received a 40‐μg dose, 39% had an anti‐HBs response 1 month after
Randomized, comparative trial of 20 μg vs 40 μg Engerix B vaccine in hepatitis B vaccine non-responders
✍ Scribed by Paul N. Goldwater
- Book ID
- 117432399
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 403 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract An outbreak of nonbacterial gastroenteritis occurred in an orphanage in December 1979. Of 54 residents, 43 were affected with acute gastroenteritis. Diarrhea was the commonest symptom. The 33‐ to 39‐nm virus‐like particles, tentatively designated as Sapporo agent, were detected in 17 (4
## Abstract The immunogenicity of a full dose (20 μg) of recombinant DNA yeast‐derived hepatitis B vaccine (Engerix‐B) was assessed in healthy neonates in order to compare three candidate vaccination schemes. After randomization 162 newborns of hepatitis B surface antigen (HBsAg) negative mothers e